As on Wednesday, Bausch Health Companies Inc (NYSE: BHC) got off with the flyer as it spiked 2.08% to $6.38, before settling in for the price of $6.25 at the close. Taking a more long-term approach, BHC posted a 52-week range of $3.96-$11.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 1.03%. Meanwhile, its Annual Earning per share during the time was 32.76%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 4.10%. This publicly-traded company’s shares outstanding now amounts to $365.24 million, simultaneously with a float of $320.77 million. The organization now has a market capitalization sitting at $2.34 billion. At the time of writing, stock’s 50-day Moving Average stood at $6.30, while the 200-day Moving Average is $7.58.
Bausch Health Companies Inc (BHC) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. Bausch Health Companies Inc’s current insider ownership accounts for 12.62%, in contrast to 78.16% institutional ownership. According to the most recent insider trade that took place on Sep 06 ’24, this organization’s EVP, General Counsel sold 13,370 shares at the rate of 6.21, making the entire transaction reach 83,028 in total value, affecting insider ownership by 435,198.
Bausch Health Companies Inc (BHC) Earnings and Revenue Records
Bausch Health Companies Inc’s EPS increase for this current 12-month fiscal period is 4.10% and is forecasted to reach 4.16 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 2.60% through the next 5 years, which can be compared against the 32.76% growth it accomplished over the previous five years trading on the market.
Bausch Health Companies Inc (NYSE: BHC) Trading Performance Indicators
Let’s observe the current performance indicators for Bausch Health Companies Inc (BHC). It’s Quick Ratio in the last reported quarter now stands at 0.82. The Stock has managed to achieve an average true range (ATR) of 0.26. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.25. Similarly, its price to free cash flow for trailing twelve months is now 2.57.
In the same vein, BHC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.29, a figure that is expected to reach 1.04 in the next quarter, and analysts are predicting that it will be 4.16 at the market close of one year from today.
Technical Analysis of Bausch Health Companies Inc (BHC)
Through scrutinizing the latest numbers posted by the [Bausch Health Companies Inc, BHC], it can be observed that its last 5-days Average volume of 3.73 million was better the volume of 3.11 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 71.98% While, its Average True Range was 0.24.
Raw Stochastic average of Bausch Health Companies Inc (BHC) in the period of the previous 100 days is set at 47.97%, which indicates a major fall in contrast to 90.41% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 19.04% that was lower than 56.51% volatility it exhibited in the past 100-days period.
